Cargando…

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases

PURPOSE: MK6240 is a second-generation tau PET tracer designed to detect the neurofibrillary tangles in the brains of patients with Alzheimer’s disease (AD). The aim of the study was to characterize (3)H-MK6240 in AD and control brain tissue and to compare its binding properties with those of first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Malarte, Mona-Lisa, Nordberg, Agneta, Lemoine, Laetitia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041708/
https://www.ncbi.nlm.nih.gov/pubmed/32970217
http://dx.doi.org/10.1007/s00259-020-05035-y
_version_ 1783677990033424384
author Malarte, Mona-Lisa
Nordberg, Agneta
Lemoine, Laetitia
author_facet Malarte, Mona-Lisa
Nordberg, Agneta
Lemoine, Laetitia
author_sort Malarte, Mona-Lisa
collection PubMed
description PURPOSE: MK6240 is a second-generation tau PET tracer designed to detect the neurofibrillary tangles in the brains of patients with Alzheimer’s disease (AD). The aim of the study was to characterize (3)H-MK6240 in AD and control brain tissue and to compare its binding properties with those of first-generation tau PET tracers. METHODS: Saturation binding assays with (3)H-MK6240 were carried out in the temporal and parietal cortices of AD brains to determine the maximum number of binding sites (Bmax) and the dissociation constants (Kd) at these sites. Competitive binding assays were carried out between (3)H-MK6240 and unlabelled MK6240, AV-1451 (aka T807, flortaucipir) and THK5117, and between (3)H-THK5351 and unlabelled MK6240. Regional binding studies with (3)H-MK6240 were carried out in homogenates from six AD and seven control brains and, using autoradiography, on large frozen sections from two AD brains and one control brain. RESULTS: The saturation binding assays gave Bmax and Kd values of 59.2 fmol/mg and 0.32 nM in the temporal cortex and 154.7 fmol/mg and 0.15 nM in the parietal cortex. The competitive binding assays revealed two binding sites with affinities in the picomolar and nanomolar range shared by (3)H-MK6240 and all the tested unlabelled compounds. There were no binding sites in common between (3)H-THK5351 and unlabelled MK6240. Regional binding of (3)H-MK6240 was significantly higher in AD brain tissue than in controls. Binding in brain tissue from AD patients with early-onset AD was significantly higher than in brain tissue from patients with late-onset AD. Binding of (3)H-MK6240 was not observed in off-target regions. Autoradiography showed high regional cortical binding in the two AD brains and very low binding in the control brain. CONCLUSIONS: (3)H-MK6240 has a high binding affinity for tau deposits in AD brain tissue but also has different binding characteristics from those of the first-generation tau tracers. This confirms the complexity of tau tracer binding on tau deposits with different binding affinities for different binding sites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-020-05035-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-8041708
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-80417082021-04-27 Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases Malarte, Mona-Lisa Nordberg, Agneta Lemoine, Laetitia Eur J Nucl Med Mol Imaging Original Article PURPOSE: MK6240 is a second-generation tau PET tracer designed to detect the neurofibrillary tangles in the brains of patients with Alzheimer’s disease (AD). The aim of the study was to characterize (3)H-MK6240 in AD and control brain tissue and to compare its binding properties with those of first-generation tau PET tracers. METHODS: Saturation binding assays with (3)H-MK6240 were carried out in the temporal and parietal cortices of AD brains to determine the maximum number of binding sites (Bmax) and the dissociation constants (Kd) at these sites. Competitive binding assays were carried out between (3)H-MK6240 and unlabelled MK6240, AV-1451 (aka T807, flortaucipir) and THK5117, and between (3)H-THK5351 and unlabelled MK6240. Regional binding studies with (3)H-MK6240 were carried out in homogenates from six AD and seven control brains and, using autoradiography, on large frozen sections from two AD brains and one control brain. RESULTS: The saturation binding assays gave Bmax and Kd values of 59.2 fmol/mg and 0.32 nM in the temporal cortex and 154.7 fmol/mg and 0.15 nM in the parietal cortex. The competitive binding assays revealed two binding sites with affinities in the picomolar and nanomolar range shared by (3)H-MK6240 and all the tested unlabelled compounds. There were no binding sites in common between (3)H-THK5351 and unlabelled MK6240. Regional binding of (3)H-MK6240 was significantly higher in AD brain tissue than in controls. Binding in brain tissue from AD patients with early-onset AD was significantly higher than in brain tissue from patients with late-onset AD. Binding of (3)H-MK6240 was not observed in off-target regions. Autoradiography showed high regional cortical binding in the two AD brains and very low binding in the control brain. CONCLUSIONS: (3)H-MK6240 has a high binding affinity for tau deposits in AD brain tissue but also has different binding characteristics from those of the first-generation tau tracers. This confirms the complexity of tau tracer binding on tau deposits with different binding affinities for different binding sites. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-020-05035-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-09-24 2021 /pmc/articles/PMC8041708/ /pubmed/32970217 http://dx.doi.org/10.1007/s00259-020-05035-y Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Malarte, Mona-Lisa
Nordberg, Agneta
Lemoine, Laetitia
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
title Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
title_full Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
title_fullStr Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
title_full_unstemmed Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
title_short Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
title_sort characterization of mk6240, a tau pet tracer, in autopsy brain tissue from alzheimer’s disease cases
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041708/
https://www.ncbi.nlm.nih.gov/pubmed/32970217
http://dx.doi.org/10.1007/s00259-020-05035-y
work_keys_str_mv AT malartemonalisa characterizationofmk6240ataupettracerinautopsybraintissuefromalzheimersdiseasecases
AT nordbergagneta characterizationofmk6240ataupettracerinautopsybraintissuefromalzheimersdiseasecases
AT lemoinelaetitia characterizationofmk6240ataupettracerinautopsybraintissuefromalzheimersdiseasecases